Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 896.90
+3.55 (0.40%)
Jan 28, 2026, 3:30 PM IST
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 898.92 billion as of January 28, 2026. Its market cap has decreased by -10.74% in one year.
Market Cap
898.92B
Enterprise Value
952.47B
Revenue
244.94B
Ranking
n/a
PE Ratio
18.27
Stock Price
896.90
Market Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 898.92B, an increase of 10,868.06%. That is a compound annual growth rate of 21.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 898.92B | -2.30% |
| Dec 31, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.60T |
| Cipla | 1.06T |
| Mankind Pharma | 870.03B |
| Alkem Laboratories | 687.56B |
| Aurobindo Pharma | 657.76B |
| Glenmark Pharmaceuticals | 555.29B |
| Laurus Labs | 548.71B |
| Ipca Laboratories | 371.12B |